Mark D. Tricklebank

Mark D. Tricklebank publication distribution in Neuroscience in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Neuroscience in 2026. The highlighted bar marks where Mark D. Tricklebank sits on this spectrum.

Mark D. Tricklebank D-index placement in Neuroscience in 2026

The chart shows the D-index (discipline H-index) distribution of Neuroscience scientists ranked by Research.com in 2026. The highlighted bar marks where Mark D. Tricklebank sits on this spectrum.

Best Publications

• The involvement of subtypes of the 5-HT1 receptor and of catecholaminergic systems in the behavioural response to 8-hydroxy-2-(di-n-Propylamino) tetralin in the rat

  Unknown

  677
  Citations

• The behavioural effects of MK-801: a comparison with antagonists acting non-competitively and competitively at the NMDA receptor

  Mark D. Tricklebank;Lakhbir Singh;Ryszard J. Oles;Cliff Preston

  649
  Citations

• Removing obstacles in neuroscience drug discovery: the future path for animal models.

  Athina Markou;Christian Chiamulera;Mark A Geyer;Mark Tricklebank

  395
  Citations

• NMDA receptors, cognition and schizophrenia – Testing the validity of the NMDA receptor hypofunction hypothesis

  Gary Gilmour;Sophie Dix;Laetitia Fellini;Francois Gastambide

  220
  Citations

• Evidence that the anxiolytic-like effects of chlordiazepoxide on the elevated plus maze are confounded by increases in locomotor activity.

  G. R. Dawson;S. P. Crawford;N. Collinson;S. D. Iversen

  206
  Citations

• The IMPROVE Guidelines (Ischaemia Models: Procedural Refinements Of in Vivo Experiments):

  Nathalie Percie du Sert;Alessio Alfieri;Stuard M. Allan;Hilary V. O. Carswell

  202
  Citations

• Subtypes of the 5-HT receptor mediating the behavioural responses to 5-methoxy-N,N-dimethyltryptamine in the rat.

  Mark D. Tricklebank;Christian Forler;Derek N. Middlemiss;John R. Fozard

  202
  Citations

• Centrally active 5-HT receptor agonists and antagonists.

  Derek N. Middlemiss;Mark D. Tricklebank

  199
  Citations

• Effect of plasma protein binding on in vivo activity and brain penetration of glycine/NMDA receptor antagonists.

  Michael Rowley;Janusz J. Kulagowski;Alan P. Watt;Denise Rathbone

  179
  Citations

• Pharmacological analysis of the behavioural and thermoregulatory effects of the putative 5-HT1 receptor agonist, RU 24969, in the rat

  M.D. Tricklebank;D.N. Middlemiss;J. Neill

  179
  Citations

• The behavioural response to 5-HT receptor agonists and subtypes of the central 5-HT receptor

  Unknown

  168
  Citations

• Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration

  Unknown

  167
  Citations

• Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor

  Mark D. Tricklebank;Joanna Neill;Emma J. Kidd;John R. Fozard

  158
  Citations

• Prefrontal cholinergic mechanisms instigating shifts from monitoring for cues to cue-guided performance: converging electrochemical and fMRI evidence from rats and humans.

  William M. Howe;Anne S. Berry;Jennifer Francois;Gary Gilmour

  150
  Citations

• Decoupling of sleep-dependent cortical and hippocampal interactions in a neurodevelopmental model of schizophrenia

  Keith G. Phillips;Ullrich Bartsch;Andrew P. McCarthy;Dale M. Edgar

  149
  Citations

• L-745,870, a Subtype Selective Dopamine D4 Receptor Antagonist, Does Not Exhibit a Neuroleptic-Like Profile in Rodent Behavioral Tests

  L J Bristow;N Collinson;G P Cook;N Curtis

  146
  Citations

• Innovative solutions to novel drug development in mental health

  T.R. Insel;V. Voon;J.S. Nye;V.J. Brown

  143
  Citations

• Mapping the central effects of ketamine in the rat using pharmacological MRI

  Clare L. Littlewood;Nicholas Jones;Michael J. O’Neill;Stephen N. Mitchell

  141
  Citations

• Shifting brain inhibitory balance and connectivity of the prefrontal cortex of adults with autism spectrum disorder.

  L A Ajram;J Horder;M A Mendez;A Galanopoulos

  141
  Citations

• One-trial tolerance to the effects of chlordiazepoxide on the elevated plus maze may be due to locomotor habituation, not repeated drug exposure

  Gerard R. Dawson;Susan P. Crawford;Kelly J. Stanhope;Susan D. Iversen

  136
  Citations